Načítá se...
Optimization and qualification of a functional anti-drug antibody assay for HIV-1 bnAbs
The recent identification of human monoclonal antibodies with broad and potent neutralizing activity against HIV-1 (bnAbs) has resulted in substantial efforts to develop these molecules for clinical use in the prevention and treatment of HIV-1 infection. As with any protein therapeutic drug product,...
Uloženo v:
| Vydáno v: | J Immunol Methods |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7103754/ https://ncbi.nlm.nih.gov/pubmed/31917969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jim.2020.112736 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|